ZEB1 and glioblastoma: A study used CRISPR-Cas9 mediated knockout of the mesenchymal transcription factor ZEB1 (zinc finger E-box binding homeobox 1) gene, one of underlying causes of resistance to bevacizumab, attenuated invasion of GBM cells [76].